Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Reza Alimohammadi"'
Autor:
Reza Alimohammadi, Ghanbar Mahmoodi Chalbatani, Masoumeh Alimohammadi, Haniyeh Ghaffari-Nazari, Arezou Rahimi, Esmail Mortaz, Nariman Mossafa, Louis Boon, Seyed Amir Jalali
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Colorectal cancer is a poorly immunogenic. Such property can be reverted by using ICD. However, ICD inducers can also induce the expression of inhibitory checkpoint receptors CD47 and PD-L1 on tumor cells, making CRC tumors resistant to main
Externí odkaz:
https://doaj.org/article/ffab9a1254464d4facc2913c9f3faf17
Autor:
Reza Alimohammadi, Meysam Porgoo, Mohamad Eftekhary, Seyed Hossein Kiaie, Ehsan Ansari Dezfouli, Maryam Dehghani, Kaveh Nasrollahi, Talieh Malekshahabi, Maryam Heidari, Sedigheh Pouya, Masoumeh Alimohammadi, Dorsa Sattari Khavas, Mohammad Sadra Modaresi, Mohammad Hossein Ghasemi, Hamed Ramyar, Fatemeh Mohammadipour, Fateme Hamzelouei, Ahmadreza Mofayezi, Seyed Saeed Mottaghi, Amirhosein Rahmati, Mohsen Razzaznian, Vista Tirandazi, Mahdi Tat, Fatemeh Borzouee, Hossein Sadeghi, Melika Haji Mohammadi, Leila Rastegar, Seyed Milad Safar Sajadi, Hossein Ehsanbakhsh, Hamed Bazmbar, Zeinab Baghernejadan, Maedeh Shams Nouraei, Pouya Pazooki, Mina Pahlavanneshan, Khadijeh Alishah, Fateme Nasiri, Neda Mokhberian, Seyedeh Shima Mohammadi, Shima Akar, Hamidreza Niknam, Marzieh Azizi, Mohammad Ajoudanian, Mohammad Hossein Moteallehi-Ardakani, Seyed Ali Mousavi Shaegh, Reihaneh Ramezani, Vahid Salimi, Reza Moazzami, Seyed Mahmoud Hashemi, Somaye Dehghanizadeh, Vahid Khoddami
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-12 (2022)
Abstract At the forefront of biopharmaceutical industry, the messenger RNA (mRNA) technology offers a flexible and scalable platform to address the urgent need for world-wide immunization in pandemic situations. This strategic powerful platform has r
Externí odkaz:
https://doaj.org/article/73e6d37fa9d9493ca146c4244680daf5
Autor:
Elham Rostami, Mohsen Bakhshandeh, Haniyeh Ghaffari-Nazari, Maedeh Alinezhad, Masoumeh Alimohammadi, Reza Alimohammadi, Ghanbar Mahmoodi Chalbatani, Ehsan Hejazi, Thomas J Webster, Jalil Tavakkol-Afshari, Seyed Amir Jalali
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0273547 (2022)
Radiotherapy as an anti-tumor treatment can stimulate the immune system. However, irradiated tumor cells express CD47 to escape the anti-tumor immune response. Anti- CD47 Immunotherapy is a possible way to tackle this problem. This study evaluated th
Externí odkaz:
https://doaj.org/article/a7a1ebefaef145f4be6f852fefc32a47
Autor:
Mohammad Javad Mousavi, Mohammad Reza Hooshangi Shayesteh, Sirous Jamalzehi, Reza Alimohammadi, Arezou Rahimi, Saeed Aslani, Nima Rezaei
Publikováno v:
Journal of Research in Medical Sciences, Vol 26, Iss 1, Pp 22-22 (2021)
Several studies have demonstrated that the genetic polymorphisms in the genes encoding immune regulatory molecules, namely cytotoxic T-lymphocyte-associated protein 4 (CTLA4) and CD28, play a fundamental role in susceptibility to rheumatoid arthritis
Externí odkaz:
https://doaj.org/article/204aa3a743064eb187f16cb928ac3e67
Autor:
Noushin Lotfi, Maryam Rastin, Parisa Shoaei, Bahram Memar, Nafiseh Sadat Tabasi, Zohreh Mahmoudi, Reza Alimohammadi, Behnam Yousefi, Mahmoud Mahmoudi
Publikováno v:
Journal of Medical Microbiology and Infectious Diseases, Vol 2, Iss 3, Pp 121-124 (2014)
Introduction: Most B-cell malignancies are diagnosed based on morphologic and immunohistochemical criteria. Some cases, however, still present a challenge for the pathologist to discriminate between reactive hyperplasia and neoplastic disorders. Mole
Externí odkaz:
https://doaj.org/article/f15084a743684935bb4a08ec5d409b32
Publikováno v:
International Journal of Energy and Environmental Engineering. 13:319-329
Autor:
Reza Alimohammadi, Meysam Porgoo, Mohamad Eftekhary, Seyed Hossein Kiaie, Ehsan Ansari Dezfouli, Maryam Dehghani, Kaveh Nasrollahi, Talieh Malekshahabi, Maryam Heidari, Sedigheh Pouya, Masoumeh Alimohammadi, Dorsa Sattari Khavas, Mohammad Sadra Modaresi, Mohammad Hossein Ghasemi, Hamed Ramyar, Fatemeh Mohammadipour, Fateme Hamzelouei, Ahmadreza Mofayezi, Seyed Saeed Mottaghi, Amirhosein Rahmati, Mohsen Razzaznian, Vista Tirandazi, Fatemeh Borzouee, Hossein Sadeghi, Melika Haji Mohammadi, Leila Rastegar, Seyed Milad Safar Sajadi, Hossein Ehsanbakhsh, Hamed Bazmbar, Maedeh Shams Nouraee, Pouya Pazooki, Mina PahlevanNeshan, Khadijeh Alishah, Fateme Nasiri, Neda Mokhberian, Seyedeh Shima Mohammadi, Shima Akar, Hamidreza Niknam, Marzyieh Azizi, Mohammad Ajoudanian, Mohammad Hossein Moteallehi-Ardakani, Seyed Ali Mousavi Shaegh, Reihaneh Ramezani, Vahid Salimi, Reza Moazzami, Seyed Mahmoud Hashemi, Somaye Dehghanizadeh, Vahid Khoddami
At the forefront of biopharmaceutical industry, the messenger RNA (mRNA) technology offers a flexible and scalable platform to address the urgent need for world-wide immunization in pandemic situations. This strategic powerful platform has recently b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a53f676e616e64d932fb8030e506bb5
https://doi.org/10.1101/2022.03.05.483092
https://doi.org/10.1101/2022.03.05.483092
Publikováno v:
Heat Transfer. 50:907-941
Autor:
Thomas J. Webster, Mahmoud Reza Jaafari, Amin Reza Nikpoor, Razieh Alibeigi, Seyed Amir Jalali, Reza Alimohammadi, Ghanbar Mahmoodi Chalbatani
Publikováno v:
International Journal of Nanomedicine. 15:5279-5288
Introduction Today, a new paradigm has emerged for cancer treatment introducing combination therapies. Doxil, a liposomal doxorubicin serving as a chemotherapeutic agent, is an effective immunogenic killer of cancer cells. Anti-CTLA-4 has been approv
Autor:
Reza Alimohammadi, Ghanbar Mahmoodi Chalbatani, Masoumeh Alimohammadi, Hanieh Ghaffari-Nazari, Arezou Rahimi, Esmail Mortaz, Nariman Mossafa, Louis Boon, Bassam Janji, Seyed Amir Jalali
Publikováno v:
SSRN Electronic Journal.